These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2866971)

  • 1. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
    Frances B; Moisand C; Meunier JC
    Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of dynorphin A and related peptides to kappa- and mu-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p.
    Gairin JE; Botanch C; Cros J; Meunier JC
    Eur J Pharmacol; 1989 Oct; 172(4-5):381-4. PubMed ID: 2573538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
    Porthé G; Francés B; Verrier B; Cros J; Meunier JC
    Life Sci; 1988; 43(6):559-67. PubMed ID: 2841553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
    Jauzac P; Frances B; Puget A; Moisand C; Meunier JC
    J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of NaCl and guanyl-5'yl-imidodiphosphate (GppNHp) on [3H]naloxone binding to kappa-opioid receptors in guinea pig cerebellum.
    Ishige K; Makimura M; Ito Y; Murakoshi Y
    Biol Pharm Bull; 1993 Sep; 16(9):921-5. PubMed ID: 8268860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions.
    Pfeiffer A; Sadée W; Herz A
    J Neurosci; 1982 Jul; 2(7):912-7. PubMed ID: 6284888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
    Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
    Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
    Ishizuka Y; Oka T; Kenjo T; Fujii A
    Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cations on binding, in membrane suspensions, of various opioids at mu-sites of rabbit cerebellum and kappa-sites of guinea-pig cerebellum.
    Kosterlitz HW; Paterson SJ; Robson LE; Traynor JR
    Br J Pharmacol; 1987 Jun; 91(2):431-7. PubMed ID: 3038237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of opioid receptors in the Mongolian gerbil cerebellum.
    Niwa M; Iwai T; Luay AE; Nozaki M; Tsurumi K
    Life Sci; 1994; 55(16):1277-83. PubMed ID: 7934629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of opioid antagonist and mu, kappa or delta agonist binding by guanine nucleotide and sodium.
    Ishizuka Y; Oka T
    Jpn J Pharmacol; 1984 Nov; 36(3):397-405. PubMed ID: 6097726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.